Related references
Note: Only part of the references are listed.FROM THE ANALYST'S COUCH Changes in clinical trial length
Lisette Pregelj et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
ClinGen - The Clinical Genome Resource
Heidi L. Rehm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Mary E. Norton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Current situation on the availability of nanostructure-biological activity data
C. Oksel et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2015)
Chromatin Changes at the PPAR-γ2 Promoter During Bone Marrow-Derived Multipotent Stromal Cell Culture Correlate With Loss of Gene Activation Potential
Patrick J. Lynch et al.
STEM CELLS (2015)
Establishing Criteria for Human Mesenchymal Stem Cell Potency
Rebekah M. Samsonraj et al.
STEM CELLS (2015)
Incorporating patient-preference evidence into regulatory decision making
Martin P. Ho et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2015)
Enabling Consistency in Pluripotent Stern Cell-Derived Products for Research and Development and Clinical Applications Through Material Standards
Anna French et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes
Tony Shen et al.
FRONTIERS IN GENETICS (2015)
Novel Bioequivalence Approach for Narrow Therapeutic Index Drugs
L. X. Yu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Nano(Q)SAR: Challenges, pitfalls and perspectives
Ratna Tantra et al.
NANOTOXICOLOGY (2015)
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
Michael Mendicino et al.
CELL STEM CELL (2014)
Improving the design of nutrition labels to promote healthier food choices and reasonable portion sizes
C. A. Roberto et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells
Peter W. Andrews et al.
NATURE BIOTECHNOLOGY (2014)
Better standards sought for range of stem cells entering the clinic
Elie Dolgin
NATURE MEDICINE (2014)
Diagnostic Clinical Genome and Exome Sequencing
Leslie G. Biesecker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Gene markers of cellular aging in human multipotent stromal cells in culture
Ian H. Bellayr et al.
STEM CELL RESEARCH & THERAPY (2014)
Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells
Jessica L. Lo Surdo et al.
CYTOTHERAPY (2013)
ACMG clinical laboratory standards for next-generation sequencing
Heidi L. Rehm et al.
GENETICS IN MEDICINE (2013)
Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells
Samuel T. Mindaye et al.
JOURNAL OF PROTEOMICS (2013)
Implementing personalized cancer genomics in clinical trials
Richard Simon et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Global proteomic signature of undifferentiated human bone marrow stromal cells: Evidence for donor-to-donor proteome heterogeneity
Samuel T. Mindaye et al.
STEM CELL RESEARCH (2013)
Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential
David A. Winkler et al.
TOXICOLOGY (2013)
Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro
Cristina Nazarov et al.
STEM CELL RESEARCH & THERAPY (2013)
Quantitative Approaches to Detect Donor and Passage Differences in Adipogenic Potential and Clonogenicity in Human Bone Marrow-Derived Mesenchymal Stem Cells
Jessica Lo Surdo et al.
TISSUE ENGINEERING PART C-METHODS (2012)
Microbial Genomics and Infectious Diseases
David A. Relman
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mesenchymal stem cell therapy: Two steps forward, one step back
James Ankrum et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Share Paper
